Plant-derived Squalene Market Analysis - Industry Trends and Best Practices

1. Market Definition & Product Landscape

1.1 What is Squalene?Squalene is a natural triterpenoid hydrocarbon (CH). In humans, it is a precursor of cholesterol and a major component of sebum (roughly 12-13%), providing natural hydration and antioxidant protection to the skin .

1.2 Types by SourceThe market is segmented into three distinct supply chains :

SOURCE TYPE
PRIMARY ORIGIN
REGULATORY STATUS IN EU COSMETICS
2034 OUTLOOK

Animal-Sourced
Shark Liver Oil
Prohibited (Annex II)
Declining / Niche

Plant-Sourced
Olive, Amaranth, Sugarcane
Fully Permitted
Dominant

Biosynthetic
Yeast/Microalgae Fermentation
Fully Permitted
Fastest-Growing

2. Market Dynamics & Forces2.1 Key Drivers

*
The "Clean Beauty" Megatrend: Consumers demand vegan, cruelty-free, and sustainably sourced ingredients. Plant-based squalene fits this narrative perfectly .

*
Vaccine Adjuvant Demand: The COVID-19 pandemic highlighted squalene's critical role in enhancing immune response (e.g., MF59 and AS03 adjuvants). R&D in flu and malaria vaccines continues to drive pharmaceutical demand .

*
Bioavailability: Squalene is highly absorbable (60-85%) and mimics human sebum, making it superior to many synthetic emollients .

2.2 Industry Challenges

*
Supply Chain Ethics: Approximately 3,000 sharks are killed to produce just 1 ton of shark-derived squalene, raising significant extinction concerns .

*
Price Volatility: Traditional sourcing relies on fishing yields, whereas plant-based sourcing is subject to agricultural commodity prices.

3. Regional Analysis: The European Stronghold

Europe is not just the largest market; it is the strictest regulator. For any supplier looking to establish credibility, understanding the EU framework is mandatory .

3.1 The EU Cosmetics Regulation (EC) No 1223/2009

*
The Ban: Shark-derived squalene is listed under Annex II (Prohibited Substances). This is an absolute barrier to entry for animal-based products in the EU cosmetic sector.

*
The Opportunity: Plant-derived and biosynthetic squalene face no restrictions and are the only compliant options for cosmetic manufacturers operating in the EU .

3.2 Pharmaceutical Standards (Ph. Eur.)References

*
Fortune Business Insights. (2026). *Squalene Market Size, Share & Industry Analysis, 2026-2034* .

*
Dasari, D., et al. (2025). Squalene: A HighValue Compound for COVID19 Vaccine Adjuvants and Beyond . IUBMB Life .

*
Global Industry Analysts. (2025). Squalene Market Report .

*
Shalu, S., et al. (2024). Microbial Squalene: A Sustainable Alternative . Engineering in Life Sciences .

*
ScienceDirect. (2024). Recent advances in squalene: Biological activities, sources, extraction, and delivery systems .

For pharma-grade squalene (vaccines), compliance with the European Pharmacopoeia (Monograph 2805) is required. While shark sources are technically still permitted here, major players like Evonik have launched GMP-grade plant-based squalene, setting a new industry benchmark for safety and purity .

3.3 Country Breakdown (2025 Data)

*
Germany: The largest single market within Europe, driven by high demand for anti-aging cosmetics.https://www.jxserum.com/other-extracts/

*
France: Hub for luxury cosmetics; high demand for "bio" and plant-based certifications.

*
UK: Strong post-Brexit independent regulatory framework that mirrors EU standards on animal cruelty .

4. Competitive Landscape & Trade4.1 Key Global Players

The market features a mix of traditional Japanese suppliers and modern biotech innovators :

*
Traditional: Kishimoto Special Liver Oil (Japan), Maruha Nichiro (Japan).

*
Plant-Based Innovators: Sophim (France), Croda (UK), Amyris (USA - Biosynthetic).

*
Emerging Chinese Suppliers: High-purity plant-sourced manufacturers are gaining significant traction, leveraging cost advantages and scalable production.

4.2 The Price Premium Matrix

*
Commodity (Shark): High volatility, ethical risks, declining acceptance.

*
Value-Added (Plant/Bio): Stable pricing, premium margins (20-30% higher), long-term contracts.

5. Future Outlook & Trends (2026-2034)

1. The Rise of Biosynthetic SqualeneMicrobial fermentation (using engineered yeast or microalgae) is the future. It offers purity independent of weather (agriculture) or fishing quotas, with a lower carbon footprint .

2. Functional Food ExpansionAs studies confirm its cholesterol-lowering and detoxification effects (see ScienceDirect, 2024), squalene is moving beyond capsules into functional beverages and fortified foods.

3. Supply Chain RegionalizationPost-pandemic, buyers are de-risking supply chains. Suppliers offering dual sourcing (e.g., Olive AND Sugarcane) will win over buyers looking for security against crop failures.

6. Strategic Recommendations for Buyers

For procurement managers and R&D directors reading this white paper:

*
Verify Your Source: If you are selling in Europe, ensure your Certificate of Analysis (COA) explicitly states "100% Plant-Derived" . Shark-derived sources are non-compliant.

*
Look for High Purity: For pharmaceutical or high-end cosmetic use, purity requirements exceed 97% . Lower purity requires additional refining.

*
Partner with Integrated Suppliers: Work with suppliers who control the manufacturing process (from crude oil to refined squalene) to ensure traceability.

Conclusion

The global squalene market is at a tipping point. Sustainability is no longer a marketing advantage; it is a regulatory requirement.

For suppliers, the message is clear: Plant-based is the only viable path forward for growth.

For buyers, the time to audit your supply chain is now. Transitioning to plant-derived or biosynthetic squalene mitigates regulatory risk, aligns with ESG goals, and meets the surging consumer demand for ethical beauty and health products.

Media Contact
Company Name: Jiangxi Serum Pharma Industries Co., Ltd.
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=plantderived-squalene-market-analysis]
Country: China
Website: https://www.jxserum.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.